Myomo (MYO) EBIAT (2016 - 2025)
Myomo (MYO) has disclosed EBIAT for 10 consecutive years, with -$3.7 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT fell 279.02% year-over-year to -$3.7 million, compared with a TTM value of -$12.0 million through Sep 2025, down 43.37%, and an annual FY2024 reading of -$6.2 million, up 24.1% over the prior year.
- EBIAT was -$3.7 million for Q3 2025 at Myomo, up from -$4.6 million in the prior quarter.
- Across five years, EBIAT topped out at -$260081.0 in Q4 2024 and bottomed at -$4.6 million in Q2 2025.
- Average EBIAT over 5 years is -$2.5 million, with a median of -$2.6 million recorded in 2023.
- The sharpest move saw EBIAT soared 89.43% in 2024, then plummeted 312.98% in 2025.
- Year by year, EBIAT stood at -$2.7 million in 2021, then increased by 20.7% to -$2.2 million in 2022, then dropped by 13.5% to -$2.5 million in 2023, then skyrocketed by 89.43% to -$260081.0 in 2024, then tumbled by 1308.37% to -$3.7 million in 2025.
- Business Quant data shows EBIAT for MYO at -$3.7 million in Q3 2025, -$4.6 million in Q2 2025, and -$3.5 million in Q1 2025.